Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.

McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH.

Antimicrob Agents Chemother. 2013 Oct;57(10):5131-3. doi: 10.1128/AAC.00607-13. Epub 2013 Jul 8.

2.

Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP.

J Antimicrob Chemother. 2011 Jul;66(7):1600-8. doi: 10.1093/jac/dkr156. Epub 2011 Apr 19.

PMID:
21508008
3.

Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.

Pogue JM, Marchaim D, Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, Bheemreddy S, Hayakawa K, Martin ET, Dhar S, Kaye KS, Lephart PR.

J Antibiot (Tokyo). 2013 Oct;66(10):625-7. doi: 10.1038/ja.2013.56. Epub 2013 May 29. No abstract available.

PMID:
23715037
4.

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.

Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C, Flamm RK.

J Antimicrob Chemother. 2011 Oct;66(10):2298-307. doi: 10.1093/jac/dkr290. Epub 2011 Jul 20.

PMID:
21775338
5.

Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.

Lesho EP, Clifford RJ, Chukwuma U, Kwak YI, Maneval M, Neumann C, Xie S, Nielsen LE, Julius MD, McGann P, Waterman PE.

Diagn Microbiol Infect Dis. 2015 Feb;81(2):119-25. doi: 10.1016/j.diagmicrobio.2014.09.017. Epub 2014 Sep 28.

PMID:
25497458
6.

Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.

Lee YL, Chen YS, Toh HS, Huang CC, Liu YM, Ho CM, Lu PL, Ko WC, Chen YH, Wang JH, Tang HJ, Yu KW, Liu YC, Chuang YC, Liu CE, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S29-36. doi: 10.1016/S0924-8579(12)70007-9.

PMID:
22749056
7.

Carbapenem resistance in Enterobacteriaceae: here is the storm!

Nordmann P, Dortet L, Poirel L.

Trends Mol Med. 2012 May;18(5):263-72. doi: 10.1016/j.molmed.2012.03.003. Epub 2012 Apr 3. Review.

PMID:
22480775
8.

Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China.

Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D, Zhang Y.

J Med Microbiol. 2012 Jan;61(Pt 1):132-6. doi: 10.1099/jmm.0.036483-0. Epub 2011 Sep 8.

PMID:
21903823
9.

Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.

Hofer B, Dantier C, Gebhardt K, Desarbre E, Schmitt-Hoffmann A, Page MG.

J Antimicrob Chemother. 2013 May;68(5):1120-9. doi: 10.1093/jac/dks527. Epub 2013 Jan 22.

PMID:
23344577
10.

Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.

Barguigua A, El Otmani F, Talmi M, Zerouali K, Timinouni M.

Diagn Microbiol Infect Dis. 2012 Jul;73(3):290-1. doi: 10.1016/j.diagmicrobio.2012.03.011. Epub 2012 Apr 20. No abstract available.

PMID:
22521054
11.

Carbapenem-resistant enterobacteriaceae: an emerging problem in children.

Logan LK.

Clin Infect Dis. 2012 Sep;55(6):852-9. doi: 10.1093/cid/cis543. Epub 2012 Jun 14. Review.

PMID:
22700827
12.

Carbapenem resistant Enterobacteriaceae carrying New Delhi metallo-β-lactamase gene (NDM-1) in Taiwan.

Wang SJ, Chiu SH, Lin YC, Tsai YC, Mu JJ.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):248-9. doi: 10.1016/j.diagmicrobio.2013.02.003. Epub 2013 Mar 18.

PMID:
23518181
13.

Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.

Woodford N, Eastaway AT, Ford M, Leanord A, Keane C, Quayle RM, Steer JA, Zhang J, Livermore DM.

J Clin Microbiol. 2010 Aug;48(8):2999-3002. doi: 10.1128/JCM.00341-10. Epub 2010 Jun 9.

14.

New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.

Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R.

J Assoc Physicians India. 2010 Mar;58:147-9.

PMID:
20848811
15.

Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).

Basu S, Singh AK, Nair GB.

Natl Med J India. 2010 Sep-Oct;23(5):261-2. No abstract available.

PMID:
21250578
16.

Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.

Ho CM, Ho MW, Liu YC, Toh HS, Lee YL, Liu YM, Huang CC, Lu PL, Liu CE, Chen YH, Ko WC, Tang HJ, Yu KW, Chen YS, Chuang YC, Wang JH, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S24-8. doi: 10.1016/S0924-8579(12)70006-7.

PMID:
22749055
17.

In vitro antimicrobial activity of doripenem, a new carbapenem.

Ge Y, Wikler MA, Sahm DF, Blosser-Middleton RS, Karlowsky JA.

Antimicrob Agents Chemother. 2004 Apr;48(4):1384-96.

18.

Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.

Zhang R, Cai JC, Zhou HW, Nasu M, Chen GX.

J Med Microbiol. 2011 Dec;60(Pt 12):1813-9. doi: 10.1099/jmm.0.025668-0. Epub 2011 Aug 11.

PMID:
21835972
19.
20.

Supplemental Content

Support Center